A top-10 pharma built three Phase III oncology studies in parallel across 30 countries on Medable's platform.

The sponsor wanted a global oncology program with multiple Phase III studies across 30 countries and 600+ sites, and needed agility and consistency as cohorts and amendments multiplied. Medable built a standardized oncology delivery model with reusable instrument libraries on its platform, eCOA+, Total Consent and Televisit. The page reports three Phase III studies delivered on time for IRB submission, 600+ sites activated, and 20-30% faster timelines than standard approaches.

Medable is a digital clinical trial platform used by pharma sponsors for eCOA, eConsent and decentralized trial delivery

This sits in the Ship stage of the AI use-case lifecycle: Named examples from the vendors pharma teams use to get an AI system live inside a real, regulated production workflow — validation, CRM, safety and clinical systems of record.